Wednesday, January 10, 2018 10:16:08 PM
Just wanted to add this as it's funny.
"For the quarter ending June 30th 2017, Easton through its host company Ackerman Pharma, received $400,000 in product purchase orders for the products Gynofit and advanced payment for product AmnioSense (AL - Sense) from its sub - distribution partner Gedeon Richter Plc and its subsidiary company. This sale has been reversed as the product has not been delivered nor paid for."
The bartender/waitress is the Chief Financial Officer now. Great!
As per last fins.
Promissory note(s) $1,588,035
Any guesses what those terms are for a zero revenue company? Just wondering. I am confident that they are in the best interests of the shareholders imo.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM